PARP Inhibitor Maintenance Therapy after Initial Chemotherapy for Advanced Ovary, Fallopian Tube and Primary Peritoneal Cancers |
|
Enduring |
|
$0.00 |
Keeping Up with the Chemos: Trabectedin and Doxorubicin - Administration (Part 2) |
|
Enduring |
|
$0.00 |
SGO/ACCC Antineoplastic Flashcards |
|
Enduring |
|
$0.00 |
Use of PARPi in Gynecologic Oncology |
|
Enduring |
|
$0.00 |
Immunotherapy Part 2: Common Controversies |
|
Enduring |
|
$0.00 |
Best of ESMO 2022 Podcast |
|
Enduring |
|
$0.00 |
Menopause with Mary Jane Minkin: HRT For Menopause Management in Benign Patients |
|
Enduring |
|
$0.00 |
The Big Reveal: 2020 State of the Society Survey- Patterns, Progress and Pathways to your Professional Future |
|
Enduring |
|
$0.00 |
SGO Late Breaking - SGO 2024 |
|
Enduring |
|
$0.00 |
SGO Taskforce for Board Certification Support: Cervical, Vulvar and Vaginal Cancer Resources - Preparing for the ABOG Oral Exam (Part 6) |
|
Enduring |
|
$0.00 |
SGO 2022 Winter Meeting |
|
Enduring |
|
$0.00 |
Health Equity in the COVID-19 Era: Understanding the Data and Strategies to Support Vulnerable Populations |
|
Enduring |
|
$0.00 |
SGO 2024 Robotics Academy: Radical Hysterectomy |
|
Enduring |
|
$0.00 |
Scientific Plenary III: Farr Nezhat Surgical Innovation Session |
|
Enduring |
|
$0.00 |
Session 6: Considerations and Risks for Gynecologic and Breast/Chest Cancers in Transgender Patients |
|
Enduring |
|
$0.00 |